US 7348004
Immunoglobulin chimeric monomer-dimer hybrids
granted A61KA61K38/00A61P
Quick answer
US patent 7348004 (Immunoglobulin chimeric monomer-dimer hybrids) held by Syntonix Pharmaceuticals, Inc. expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Syntonix Pharmaceuticals, Inc.
- Grant date
- Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61P, A61P9/00, A61P9/10